三取代2-哌嗪基噻唑的抗菌评价

Q3 Pharmacology, Toxicology and Pharmaceutics

ACTA Pharmaceutica Sciencia Pub Date : 2019-01-01 DOI:10.23893/1307-2080.APS.05707

B. Giray, L. Yurttaş, Z. Şahin, B. Berk, Ş. Demirayak

{"title":"三取代2-哌嗪基噻唑的抗菌评价","authors":"B. Giray, L. Yurttaş, Z. Şahin, B. Berk, Ş. Demirayak","doi":"10.23893/1307-2080.APS.05707","DOIUrl":null,"url":null,"abstract":"Bacterial resistance to the treatment of infectious diseases is the main problem. Many classes of antibiotics are facing resistance and have initiated new efforts to develop new derivatives and discover new chemical classes.1 Gram positive and gram-negative bacteria such as Escherichia coli, Staphylococcus aureus, Micrococcus luteus, Bacillus subtilis, Bacillus cereus, Pseudomonas aeruginosa etc. are responsible for many diverse infections which even can cause of death.2","PeriodicalId":6962,"journal":{"name":"ACTA Pharmaceutica Sciencia","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles\",\"authors\":\"B. Giray, L. Yurttaş, Z. Şahin, B. Berk, Ş. Demirayak\",\"doi\":\"10.23893/1307-2080.APS.05707\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Bacterial resistance to the treatment of infectious diseases is the main problem. Many classes of antibiotics are facing resistance and have initiated new efforts to develop new derivatives and discover new chemical classes.1 Gram positive and gram-negative bacteria such as Escherichia coli, Staphylococcus aureus, Micrococcus luteus, Bacillus subtilis, Bacillus cereus, Pseudomonas aeruginosa etc. are responsible for many diverse infections which even can cause of death.2\",\"PeriodicalId\":6962,\"journal\":{\"name\":\"ACTA Pharmaceutica Sciencia\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACTA Pharmaceutica Sciencia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23893/1307-2080.APS.05707\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACTA Pharmaceutica Sciencia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23893/1307-2080.APS.05707","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}

引用次数: 1

摘要

细菌对传染病的耐药性是治疗的主要问题。许多种类的抗生素正面临耐药性，人们开始努力开发新的衍生物和发现新的化学类别革兰氏阳性和革兰氏阴性细菌，如大肠杆菌、金黄色葡萄球菌、黄体微球菌、枯草芽孢杆菌、蜡样芽孢杆菌、铜绿假单胞菌等，可引起多种感染，甚至可导致死亡

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles

Bacterial resistance to the treatment of infectious diseases is the main problem. Many classes of antibiotics are facing resistance and have initiated new efforts to develop new derivatives and discover new chemical classes.1 Gram positive and gram-negative bacteria such as Escherichia coli, Staphylococcus aureus, Micrococcus luteus, Bacillus subtilis, Bacillus cereus, Pseudomonas aeruginosa etc. are responsible for many diverse infections which even can cause of death.2

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ACTA Pharmaceutica Sciencia Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

CiteScore

0.90

自引率

0.00%

发文量

期刊介绍： Acta Pharmaceutica Sciencia (Acta Pharm. Sci.), formerly known as Bulletin of Pharmacy and Acta Pharmaceutica Turcica is a peer-reviewed scientific journal publishing current research and reviews covering all fields of pharmaceutical sciences since 1953. The original studies accepted for publication must be unpublished work and should contain data that have not been published elsewhere as a whole or a part. The reviews must provide critical evaluation of the state of knowledge related with the subject. All manuscripts has to be written in clear and concise English. Starting from 2016, the journal will be issued quarterly both in paper and on-line formates also publish special issues for national or international scientific meetings and activities in the coverage field.